News

ABLE & Biocon chief Kiran Mazumdar-Shaw to head biotech innovation council NBRIC

The National Biomedical Resources Indigenization Consortium(NBRIC) aims to make India self sufficient in manufacturing critical vaccines, diagnostics, reagents and therapeutics to tackle ongoing pandemic like COVID-19 and other future pandemics.

Read More

May 16, 2020

By : Team ABLE

COVID-19 : Basics of Drugs and Vaccines in progress

Any questions about the immune system, antibodies, and drug responses? Do post them in the comments section and we will help you understand better.

Read More

May 16, 2020

By : Anu Acharya

Boehringer Ingelheim, CDR-Life collaborate to develop antibody fragment-based therapeutics to treat blindness

The collaboration with CDR-Life is the second strategic partnership within a year for Boehringer Ingelheim in retinal diseases.

Read More

May 14, 2020

By : Team ABLE

Interim Favipiravir clinical trials show good results on COVID-19 patients in Russia

At least 60% of 40 patients in the study tested negative for COVID-19 after 5 days of Favipiravir. Russian agencies hope to start commercial supply of drug by Ma-end

Read More

May 14, 2020

By : Team ABLE

Glenmark initiates phase 3 clinical trials on antiviral Favipiravir for COVID-19 patients in India

About 150 COVID-19 patients from over 10 leading government and private hospitals in India are being enrolled for the study.

Read More

May 13, 2020

By : Team ABLE

 

Exhibit in the 'India Pavilion' at BIO 2026

June 22-25 | San Diego, USA

Indian Startup Delegations to the USA & UK

Applications Open

Focus Areas

Highlights